CVKD - CIK 0001937993
Cadrenal Therapeutics, Inc. trades as CVKD. This page tracks Cadrenal Therapeutics, Inc. through 237 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-11 |
| Major company event | 8-K | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-04-30 |
| EFFECT | - | 2026-04-29 |
| 424B3 | - | 2026-04-29 |
| Company correspondence | CORRESP | 2026-04-27 |
The largest companies sharing Cadrenal Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Cadrenal Therapeutics, Inc. reported a net loss of $13.24M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.